Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.004 Å; R factor = 0.036; wR factor = 0.099; data-to-parameter ratio = 7.4.
The title compound, C 11 H 14 N 2 OÁH 2 O, crystallizes with one formula unit in the asymmetric unit. The seven-membered ring has a chair conformation with the C O group turned away from the benzene ring. N-HÁ Á ÁO and O-HÁ Á ÁO hydrogen bonds are present in the crystal structure.
Related literature
For related literature, see: Allen et al. (1987) ; Ding et al. (1999) ; Grunewald et al. (1996) ; Kim (1976) .
Experimental
Crystal data C 11 H 14 N 2 OÁH 2 O M r = 208.26 Tetragonal, P4 3 a = 10.8251 (8) Å c = 9.4569 (14) Å V = 1108.2 (2) Å 3 Z = 4 Mo K radiation = 0.09 mm À1 T = 296 (2) K 0.20 Â 0.20 Â 0.15 mm
Data collection
Bruker APEXII CCD diffractometer Absorption correction: none 5758 measured reflections 1043 independent reflections 972 reflections with I > 2(I) R int = 0.016 Refinement R[F 2 > 2(F 2 )] = 0.035 wR(F 2 ) = 0.098 S = 1.07 1043 reflections 140 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Á max = 0.21 e Å À3 Á min = À0.20 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Data collection: APEX2 (Bruker, 2000); cell refinement: SAINT (Bruker, 2000); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL. 4-Acetyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine Q.-J. Zhao, Z. Liu, J. Zheng and J.-S. Shen
Comment
The title molecule (Fig. 1) is an important imtermediate used to synthesize a variety of pharmaceuticals, such as inhibitors of phenylethanolamine N-methyltransferase (Grunewald et al., 1996) and inhibitors of Farnesyltransferase (Ding et al., 1999) .
In our recent research for exploring new methods for synthesis of benzodiazepine derivatives, 4-acetyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine is synthesized in 96% yield from 2,3,4,5-tetrahydro-1H-1,4-benzodiazepine (Ding et al., 1999) . We report here the crystal structure of the title compound, which crystallizes in the tetragonal space group P4(3) with one H 2 O molecule in the asymmetric unit.
A view of the molecular structure of title compound is depicted in Fig.1 . The central seven-membered ring has an chair conformation, which is consistent with reported exo conformational form with the C=O group turns away from benzene ring (Kim et al., 1976) . All bond lengths and angles are normal (Allen et al., 1987) . Molecules related by an c-axis translation are stacked over each other and stabilized by van de waals (Fig. 2) . The stacked columns are linked together via an intermolecular hydrogen bond, in which the amine H1 act as a donor to H 2 O O1w atom and H 2 O H1A as a donor to H 2 O O1w atom ( Fig. 2 and Table 1 ).
Experimental
Acetyl chloride (6 ml) was added dropwise to CH 2 Cl 2 solution (80 ml) containing 2,3,4,5-tetrahydro-1H-1,4-benzodiazepine (14.8 g, 0.1 mol) at ice-water bath. After addition, the reaction temperature was raised to room temperature. The resulting mixture was crashed to ice-water bath after stirring for 5 hrs. The organic layer was separated and dried over MgSO 4 . After filtration, the filtrate was evaporated to give an oil which can be crystallized from acetone to give title compound in 96% yield. Single crystals suitable for X-ray analysis (m.p. 358 K) were obtained by slow evaporation of a ethyl acetate/n-hexane/H 2 O solution at 298 K.
Refinement
The water H atoms and imine H atom were located from Fourier difference maps and refined subject to an O-H restraint of 0.85Å and N-H 0.88 Å. Other H atoms were introduced at calculated positions (C-H = 0.93-0.97 Å) and refined using a riding model. The isotropic displacement parameters of all H atoms were set to 1.2 times U eq of the parent atoms. Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) (3) 158 (4) Symmetry codes: (i) y, −x+1, z+1/4. Fig. 1 supplementary materials sup-7 Fig. 2 
